Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Introduction</h3><p>Infections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported. The aim of this study was to perform a review to describe neurological manifestations in patients with COVID‐19 and possible neuro‐invasive mechanisms of Sars‐CoV‐2.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Pubmed, WebOfScience and Covid‐dedicated databases were searched for the combination of COVID‐19 terminology and neurology terminology up to May 10<sup>th</sup> 2020. Social media channels were followed‐up between March 15<sup>th</sup> and May 10<sup>th</sup> 2020 for postings with the same scope. Neurological manifestations were extracted from the identified manuscripts and combined to provide a useful summary for the neurologist in clinical practice. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Neurological manifestations potentially related to COVID‐19 have been reported in large studies, case series and case reports and include acute cerebrovascular diseases, impaired consciousness, cranial nerve manifestations and auto‐immune disorders such as Guillain‐Barré Syndrome often present in patients with more severe COVID‐19. Cranial nerve symptoms such as olfactory and gustatory dysfunctions are highly prevalent in patients with mild‐to‐moderate COVID‐19 even without associated nasal symptoms and often present in an early stage of the disease.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Physicians should be aware of the neurological manifestations in patients with COVID‐19, especially when rapid clinical deterioration occurs. The neurological symptoms in COVID‐19 patients may be due to direct viral neurological injury or indirect neuroinflammatory and autoimmune mechanisms. No antiviral treatments against the virus or vaccines for its prevention are available and the long‐term consequences of the infection on human health remain uncertain especially with regards to the neurological system.</p></section>

The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience

SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism

Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID‐19

Neurological Manifestations of Patients with COVID-19: Potential Routes of SARS-CoV-2 Neuroinvasion from the Periphery to the Brain

Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection

Neurological complications caused by SARS-CoV-2

Neurological complications and infection mechanism of SARS-CoV-2

Neuropathogenesis of SARS-CoV-2 infection

COVID-19: Neuroinvasiveness, Neurotropism and Neurovirulence

Sars-COV-2 infection leads to neurodegenerative or neuropsychiatric diseases

Current Clinical Findings of Acute Neurological Syndromes after SARS‐CoV‐2 Infection

COVID-19’s Pathways to Human Central Nervous System and Relevant Drug Treatment

Nervous system involvement after infection with COVID-19 and other coronaviruses

What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS‐CoV‐2

Neurological manifestations and neuro‐invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2

Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2

Single-cell sequencing of brain tissues reveal the central nervous system's susceptibility to SARS-CoV-2 and the drug

The Possible Impairment of Respiratory‐related Neural Loops May Be Associated with the Silent Pneumonia Induced by SARS‐CoV‐2

Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models